The increasingly rapid development, adoption, and proliferation of technology has put in motion a strong trend toward globalisation. As companies expand sales into new markets, they may find themselves facing litigation in more than one jurisdiction. This article provides five strategy considerations when facing cross-border litigation and explores potential pitfalls to avoid. Cross-border litigation can … Continue reading “Top five strategy considerations for managing cross-border litigation”
The collection of evidence in IP cases in France is a hot topic over the last two years or so. Several traps should now be avoided to have reliable evidence showing the alleged infringement before the courts.
How do you define a corporate crisis? According to Dan Tench, dispute resolution partner at CMS, this is where a business finds itself at the centre of a media storm in a way that overwhelms its management and its operations. ‘The defining characteristic of a crisis of this type is that the legal and operational … Continue reading “Not such a dark art”
Compliance programmes are firmly back in the global spotlight when it comes to cartel enforcement in 2019. In Europe, the Italian competition authority recently published guidance outlining what it perceives to be the key elements of an effective antitrust compliance programme and formalising a process for granting a reduction in cartel fines where the right … Continue reading “Legal 500 Cartels Guide: Corporate Compliance and Cartels”
Legal Briefing | International Comparative Guides | Torys LLP
By Sylvie Rodrigue Ad. E. and Grant Worden In Canada, the sale of pharmaceuticals and medical devices is regulated by Health Canada under the Food and Drug Act and Regulations and related legislation (Canadian Food Inspection Agency Act, SC 1997 c.6; Consumer Packaging and Labelling Act, RSC 1985, c. C-38; Consumer Packaging and Labelling Regulations, … Continue reading “Product liability in Canada”